Boehringer Ingelheim
Last updated on 2013-11-20T06:39+0300.
About this
image
License:
UNKNOWN
| Key Titles and Phrases | Count | Lang | Last Seen |
|---|---|---|---|
| farmacêutica alemã | 40.00% | PT | 29/12/2016 |
| farmacêutica | 20.00% | PT | 24/05/2016 |
| manufacturer | 20.00% | EN | 23/03/2015 |
| german manufacturer | 20.00% | EN | 23/03/2015 |
| Names | Lang | Count |
|---|---|---|
| Boehringer Ingelheim | EN | 61.60% |
| Boehringer Ingelheim | FR | 14.81% |
| Boehringer Ingelheim Pharmaceuticals | EN | 3.55% |
| Boehringer Ingelheim | PT | 3.10% |
| Boehringer Ingelheim | ES | 2.34% |
| Boehringer Ingelheim | PL | 2.19% |
| Boehringer Ingelheim | DE | 2.19% |
| Boehringer Ingelheim | IT | 2.12% |
| Boehringer Ingelheim | EU | 2.04% |
| Boehringer Ingelheim | SV | 2.04% |
| Boehringer-Ingelheim | EN | 1.74% |
| Boehringer-Ingelheim | FR | 1.51% |
| Boehringer-Ingelheim Pharmaceuticals | EN | 0.23% |
| Boehringer Ingelheim | AR | 0.15% |
| BOEHRINGER INGELHEIM | EN | 0.08% |
| Boehringer-Ingelheim Pharmaceuticals | FR | 0.08% |
| Boehringer Ingelheim Pharmaceuticals | PT | 0.08% |
| Boehringer Ingelheim Pharmaceuticals | ES | 0.08% |
| Boehringer-Ingelheim | DE | 0.08% |
| ベーリンガーインゲルハイム | JA | 0.00% |
| 勃林格殷格翰 | ZH | 0.00% |
| Type | Entity Name | Count |
|---|---|---|
 | Inc | 6.67% |
| Pfizer Inc | 3.43% |
| Novartis | 3.33% |
| Pharmaceuticals Inc | 1.96% |
| GlaxoSmithKline | 1.86% |
| Eli Lilly | 1.76% |
| Five Forces | 1.76% |
| Bristol Myers Squibb | 1.57% |
| SA | 1.47% |
| Drug Administration | 1.27% |
| World Health Organization | 1.27% |
 | Commission | 1.18% |
| Teva Pharmaceuticals | 1.18% |
| Laura Wood | 1.08% |
| Novo Nordisk | 1.08% |
| Strategy | 1.08% |
| Risk Factors | 0.98% |
| GlaxoSmithKline Plc | 0.98% |
| Association | 0.88% |
| Solutions | 0.88% |
| European Union | 0.78% |
| Lonza Group | 0.78% |
| Product Development | 0.78% |
| Roche Holding AG | 0.69% |
| Dr Reddy | 0.69% |
| Read More | 0.69% |
| Nadeem Ashraf | 0.69% |
| Table | 0.69% |
| European Commission | 0.69% |
| China International | 0.59% |
| Type | Entity Name | Score |
|---|---|---|
| Bernd Wegener | 0.1053 |
| Trinity College di Dublino | 0.1 |
| Rob van Dijk | 0.0833 |
| Novartis | 0.0334 |
| Magna Grecia di Catanzaro | 0.0323 |
| Pharmaceuticals Inc | 0.0196 |
| GlaxoSmithKline | 0.0184 |
| Five Forces | 0.018 |
| Nadeem Ashraf | 0.0166 |
| Bristol Myers Squibb | 0.0157 |
| Inc | 0.0133 |
| Novo Nordisk | 0.0119 |
| Teva Pharmaceuticals | 0.0117 |
| Laura Wood | 0.0116 |
| Eli Lilly | 0.0114 |
| Olivier Fleurot | 0.0103 |
| Nicolas Poirier | 0.0102 |
| IMS Health Inc | 0.0101 |
| GlaxoSmithKline Plc | 0.0098 |
| SA | 0.0095 |
| Sir John Gurdon | 0.0094 |
| Risk Factors | 0.009 |
| Product Development | 0.0082 |
| Drug Administration | 0.0081 |
| Lonza Group | 0.008 |
| Clostridium Difficile | 0.0079 |
| Solutions | 0.0071 |
| Roche Holding AG | 0.007 |
| Dr Reddy | 0.0067 |
| Table | 0.0067 |
Show/hide duplicate news articles.
Show/hide duplicate news articles.
Tools
Friday, January 22, 2021
11:01:00 PM EAT
Languages 
Select your languages
Explore Relations
Please send any comments or suggestions to 